Advertisement ABR-Affinity BioReagents expands distribution partners in Europe - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ABR-Affinity BioReagents expands distribution partners in Europe

ABR-Affinity BioReagents, a global antibody manufacturer, has announced the finalization of new distribution agreements with LuBioScience, headquartered in Lucerne, Switzerland and Bio-Kasztel, located in Budapest, Hungary, further expanding its already extensive network of distribution partners in Europe.

With the recent launch of over 1,600 new products in the areas of neuroscience, cancer biology, immunology, inflammation and arthritis, diabetes and vision research, ABR-Affinity BioReagents’s portfolio of high quality antibodies is said to grow in breadth and depth of research reagents available worldwide.

Ken Wilczek, president of ABR-Affinity BioReagents, said: “These types of international distribution arrangements allow us the ability and flexibility to offer our quality guaranteed experimental research tools to foreign-based scientists who are active in the worldwide effort to combat disease and enhance the quality of life for everyone.”